On May 5, 2025, bioAffinity Technologies, Inc. disclosed a public offering of 7.78 million shares and warrants, raising approximately $3.2 million for working capital. The price per share was set at $0.32, and the offering includes restrictions on issuing additional shares for 60 days post-closing.